We have been active in France for nearly 30 years and are proud to have been one of the first biotech companies to enter the local…
In Conversation
Brexit is a great tragedy for everyone and it is a concerning development for Britain and Europe in my opinion. It is, however, an opportunity for…
A circular economy is not a hippy fantasy, but good business, as it helps cutting costs while bringing extra benefits
The problem that we have had is an unprecedented drop in price over the past couple of years
President Macron’s plans will have an indirect impact on the CEPS, as they will undoubtedly cause a shift in the way that medical products, therapies and…
The most important achievement was the accreditation as a comprehensive cancer centre by the OECI
From our roots as a French company, we have blossomed into a growing international player within the areas of oncology, neuroscience and rare disease
The CNRS has activity in nearly every field of science
How can the use of data science revolutionize healthcare? How about education? These are two examples of the multifaceted and distinct problems we are tasked with…
I see great potential in the medical applications of AI and other technologies, and I wanted to gain a better understanding and play a bigger role…
The strength lies in the fact that there is a strong expertise on the scientific and the clinical side of things. What we are missing and…
I believe that we can make France a worldwide leader in the field of pharmacoepidemiology and in real-life studies.
